“NH001–Cognitive Recovery After Severe Brain Injury”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale

Neal Farber of NeuroHealing Pharmaceuticals  joined us for World Orphan Drug Congress USA 2014 to present about ‘ NH001–Cognitive Recovery After Severe Brain Injury’ .
Download his presentation now  to learn about:

  • Medical rationale for use of dopaminergics for recovering consciousness in TBI
  • Rationale for use of NH001
  • NH001-1 Pilot Study Results
  • NH001-2 Study Design
…and much more!
Get your copy here!
To find out more about how  NH001 can provide cognitive recovery after severe brain injury , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.